Buy Rating on ARS Pharmaceuticals Amid Strong Neffy Approval Prospects and Indication Expansion
TipRanksMar 25 09:25
Ars Pharmaceuticals' Merger May Limit Use of Net Operating Losses, Impacting Future Financials
TipRanksMar 23 14:01
ARS Pharmaceuticals Analyst Ratings
BenzingaMar 11 20:44
Neffy's Market Potential and ARS Pharmaceuticals' Buy Rating Reinforced by Clinical Success
TipRanksMar 11 18:45
ARS Pharmaceuticals Analyst Ratings
BenzingaMar 5 20:10
Hold Rating Maintained for ARS Pharmaceuticals Amid FDA Approval Process and Commercialization Concerns
TipRanksFeb 22 13:16
Buy Rating Affirmed: ARS Pharmaceuticals' Neffy Shows Promise in Clinical Trials With Strong Market Potential
TipRanksFeb 7 00:05
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), Wave Life Sciences (WVE) and AC Immune SA (ACIU)
TipRanksNov 14, 2023 16:20
ARS Pharmaceuticals Analyst Ratings
BenzingaNov 13, 2023 21:59
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Healthequity (HQY)
TipRanksNov 13, 2023 20:11
ARS Pharmaceuticals Analyst Ratings
BenzingaSep 21, 2023 21:28
Wedbush Sticks to Their Buy Rating for ARS Pharmaceuticals (SPRY)
TipRanksSep 21, 2023 18:55
ARS Pharmaceuticals Analyst Ratings
BenzingaSep 20, 2023 18:08
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), National Health Investors (NHI) and ARS Pharmaceuticals (SPRY)
TipRanksSep 20, 2023 16:50
Wedbush Remains a Buy on ARS Pharmaceuticals (SPRY)
TipRanksAug 14, 2023 20:36
Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $15 Price Target
BenzingaAug 14, 2023 20:17
ARS Pharmaceuticals Analyst Ratings
BenzingaAug 14, 2023 20:17
SVB Securities Sticks to Its Buy Rating for ARS Pharmaceuticals (SPRY)
TipRanksJun 22, 2023 17:55
Wedbush Maintains Outperform on ARS Pharmaceuticals, Lowers Price Target to $15
BenzingaJun 21, 2023 20:46
Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and ARS Pharmaceuticals (SPRY)
TipRanksJun 21, 2023 19:00
No Data
No Data